Health outcomes in acromegaly: depression and anxiety are promising targets for improving reduced quality of life

Autor: Victor Jacobus Geraedts, Christina eDimopoulou, Matthias eAuer, Jochen eSchopohl, Günter Karl Stalla, Caroline eSievers
Jazyk: angličtina
Rok vydání: 2015
Předmět:
Zdroj: Frontiers in Endocrinology, Vol 5 (2015)
Druh dokumentu: article
ISSN: 1664-2392
DOI: 10.3389/fendo.2014.00229
Popis: IINTRODUCTION. Remission criteria of acromegaly are based on biochemical variables, i.e. normalization of increased hormone levels. However, the established reduction in Quality of Life (QoL) is suggested to be independent of biochemical control. The aim of this study was to test which aspects predict Qol best in acromegaly. METHODS/Design. This is a prospective cohort study in 80 acromegalic patients, with a cross-sectional and longitudinal part. The main outcome measure was health-related quality of life (QoL), measured by a generic and a disease-specific questionnaire (the SF-36 and AcroQol). Main predictors were age, gender, biochemical control, disease characteristics, treatment modalities and psychopathology. RESULTS. Our cohort of 80 acromegalics had a mean age 54.7 ± 12.3 years with an average disease duration of 10.8 ± 10.0 years. Ratio macro-/microadenoma was 54/26. In adjusted mixed method models, we found that psychopathology significantly predicts QoL in acromegaly (in models including the variables age, gender, disease duration, tumor size, basal hormone levels, relevant treatment modalities and relevant comorbidities), with a higher degree of psychopathology indicating a lower QoL (depression vs. AcroQoL: B=-1.175, p
Databáze: Directory of Open Access Journals